These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 32557804)
1. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation. Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804 [TBL] [Abstract][Full Text] [Related]
2. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease. Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715 [TBL] [Abstract][Full Text] [Related]
3. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. Liu X; Chen S; Zhang L Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319 [TBL] [Abstract][Full Text] [Related]
4. LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression. Zhang T; Duan J; Zhang L; Li Z; Steer CJ; Yan G; Song G Hepatology; 2019 Apr; 69(4):1488-1503. PubMed ID: 30281809 [TBL] [Abstract][Full Text] [Related]
5. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy. Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816 [TBL] [Abstract][Full Text] [Related]
6. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans. Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141 [TBL] [Abstract][Full Text] [Related]
7. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366 [TBL] [Abstract][Full Text] [Related]
8. The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation. Kim H Sci Rep; 2016 Nov; 6():37280. PubMed ID: 27869139 [TBL] [Abstract][Full Text] [Related]
9. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis. Kim JH; Jung DY; Kim HR; Jung MH Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594 [TBL] [Abstract][Full Text] [Related]
10. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway. Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024 [TBL] [Abstract][Full Text] [Related]
12. A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism. Xu Y; Zalzala M; Xu J; Li Y; Yin L; Zhang Y Nat Commun; 2015 Jun; 6():7466. PubMed ID: 26100857 [TBL] [Abstract][Full Text] [Related]
13. Let-7i-Induced Atg4B Suppression Is Essential for Autophagy of Placental Trophoblast in Preeclampsia. Xu Y; Huang X; Xie J; Chen Y; Fu J; Wang L J Cell Physiol; 2017 Sep; 232(9):2581-2589. PubMed ID: 27770612 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease. Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes. Zhong D; Huang G; Zhang Y; Zeng Y; Xu Z; Zhao Y; He X; He F Cell Signal; 2013 Jun; 25(6):1429-37. PubMed ID: 23499676 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596 [TBL] [Abstract][Full Text] [Related]
17. Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Wang Q; Bu Q; Xu Z; Liang Y; Zhou J; Pan Y; Zhou H; Lu L Clin Mol Hepatol; 2024 Jul; 30(3):515-538. PubMed ID: 38726504 [TBL] [Abstract][Full Text] [Related]
18. An Endoplasmic Reticulum Stress-MicroRNA-26a Feedback Circuit in NAFLD. Xu H; Tian Y; Tang D; Zou S; Liu G; Song J; Zhang G; Du X; Huang W; He B; Lin W; Jin L; Huang W; Yang J; Fu X Hepatology; 2021 Apr; 73(4):1327-1345. PubMed ID: 32567701 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD. Agarwal N; Iyer D; Gabbi C; Saha P; Patel SG; Mo Q; Chang B; Goswami B; Schubert U; Kopp JB; Lewis DE; Balasubramanyam A Sci Rep; 2017 Oct; 7(1):13362. PubMed ID: 29042644 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]